COMMUNIQUÉS West-GlobeNewswire

Capsa Healthcare Unveils the New Tryten P-Series: Engineering a Path to Better Care
25/09/2024
COLUMBUS, Ohio, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Capsa Healthcare, a leader in purposefully designed integrated solutions, proudly announces the launch of the new Tryten P-Series tablet and monitor carts that are [...]
Spinogenix Announces Launch of a Phase 2 Clinical Trial Evaluating SPG302 for the Treatment of Schizophrenia
25/09/2024
Phase 2 trial is designed to evaluate the safety, efficacy, tolerability, and pharmacodynamics of SPG302 in adults with a primary diagnosis of schizophrenia LOS ANGELES, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Spinogenix, [...]
Dallas Business Journal Recognizes USOSM COO Alisa Ulrey for Leadership
25/09/2024
IRVING, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Dallas Business Journal has selected U.S. Oral Surgery Management (USOSM) Chief Operations Officer Alisa Ulrey as a 2024 C-Suite Leaders Awards program honoree. The C- [...]
Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study
25/09/2024
- Patients are preselected for CDKN2A and/or CDKN2B abnormalities - - Safety and efficacy data to be reported at an upcoming oncology medical conference - BERKELEY HEIGHTS, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- [...]
ClinicalTrials.EU platform rolled out across Europe
25/09/2024
LONDON, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The European Clinical Trials Information Network ( ClinicalTrials.EU ) has today announced its official rollout across the continent. The patient-centric platform aims to solve [...]
Koelis Announces New Compact 3D Probe to Improve Workflow and Reprocessing
25/09/2024
New 3D Ultrasound Probe maximizes auto reprocessing compatibility New probe adaptor improves needle guidance for targeted biopsy and treatment GRENOBLE, France and PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
25/09/2024
Please see enclosed pdf. Attachment 25092024_trading_in_shares_N_P_Louis-Hansen_ApS
InBrain Pharma to Present Positive Results from Its DIVE-I Phase I/II Clinical Trial for Parkinson’s Disease at the Congress of Parkinson’s Disease and Movement Disorders from September 27 to October 1 in Philadelphia
25/09/2024
Lille, September 25, 2024 - InBrain Pharma, a biopharmaceutical company specialized in neurodegenerative diseases, will present the positive results of its Phase I/II DIVE-I clinical trial for Parkinson’s disease at the [...]
Sanner Group acquires Gilero to expand its global medical device offering
25/09/2024
Sanner Group acquires Gilero to expand its global medical device offering Acquisition drives Sanner Group’s mission to offer a suite of world leading development and manufacturing services for its customers across the [...]
SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout
25/09/2024
VANCOUVER, British Columbia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ” or the “ Company ”) provides the following update: Dear Shareholders, We are [...]
GoLiver Therapeutics is the winner of the France 2030 “innovation in Biotherapies and Bioproduction” call for its GOCLINICALS project, dedicated to a novel stem cell-based liver therapy
25/09/2024
Press release GoLiver Therapeutics has been awarded €1.6m from France 2030 to progress its first biomedicine, developed from pluripotent stem cells, into the clinic for the treatment of severe liver failures. Nantes, [...]
QHSLab Secures Grant Sponsorship from a Global Leader in Consumer Health to Advance Digital Medicine Tools for Allergy Management in the Primary Care Setting
25/09/2024
WEST PALM BEACH, FL, Sept. 25, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based [...]
Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
25/09/2024
– Through selective inhibition of proinflammatory transcription, p300 KAT inhibition modulates the activity and function of multiple pro-inflammatory signaling pathways that drive chronic inflammatory diseases – – Oral [...]
GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment
25/09/2024
Live video webcast on Wednesday, October 2 nd at 12:00 PM ET LA JOLLA, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology company advancing an [...]
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
24/09/2024
LOS ANGELES, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces a groundbreaking collaboration with PreCheck Health Services Inc., a CLIA- [...]
Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2024 Conference Call for Monday, September 30, 2024
24/09/2024
GARDNER, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
24/09/2024
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]
Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day
24/09/2024
SOUTH SAN FRANCISCO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with [...]
Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market
24/09/2024
-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict the risk of preeclampsia in pregnant women- -The PrePsia test can [...]

Pages